~~<i id='9131B3B2E9'><strike id='9131B3B2E9'><tt id='9131B3B2E9'><pre id='9131B3B2E9'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

entertainment

author：Wikipedia 2025-09-30 00:39:55 - browse：91

Sarepta Therapeutics said Monday afternoon that its gene therapy for Duchenne muscular dystrophy failed to improve muscle function compared to a placebo in a large clinical trial — likely a major disappointment for patients and doctors who have been desperately awaiting the treatment for years.

The company said all patients in the study improved and that secondary measurements indicated the drug was having an effect. Nevertheless, the results are likely to raise questions about whether the Food and Drug Administration will expand access to the medicine.

Trading in Sarepta shares was halted at $107 with the release of the study results.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： First over

focus

Wikipedia

explore

focus

explore

AscientistworkingatSQZBiotechnologiesinWatertown,Mass.DavidLRyan/GlobeStaffNextstop:BeaconHill.Gover

WSS

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Medicare drug price negotiation hearing pits pharma v Biden admin

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

Think you might have Covid

Florida health officials providing scant details on measles cases

The surgeon had a dilemma only a Nazi medical text could resolve

leisure time

entertainment

focus

Affirmative action in medical school literally saved lives

Readout Newsletter: Merck, J&J, and long Covid

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Biden's 'march

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

ChatGPT in medicine: STAT answers readers' burning questions

The untold story of TV’s first prescription drug ad

Activists slam private health insurers over coverage restrictions

Elizabeth Holmes banned from government health programs

Wikipedia

Harvard's David Sinclair gets blowback over aging

Readout Newsletter: BridgeBio, Akero, and human embryo models

IVF doctors demand details after CooperSurgical lawsuit

FDA clears AI tool for detecting skin cancer

Prior authorization will have to move faster under new Biden rule

EU regulator recommends expanding Mounjaro approval to obesity

explore

focus

explore

explore